BTG3 and COVID-19: Previous studies suggested that the proportion of ANA positivity was higher in patients with severe or critical COVID-19 than in patients with mild or moderate COVID-19 and the prognosis of ANA-positive patients was worse (Peker et al., 2021; Brianza-Padilla et al., 2022; Nasarallah et al., 2022).